Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP338029.RAnKTIh1glBowyTHUZhqw8BQusH_8aTB4DQvaCQO_8Leo130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338029.RAnKTIh1glBowyTHUZhqw8BQusH_8aTB4DQvaCQO_8Leo130_provenance.
• NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_provenance.
• NP923097.RAddfFcpacvImHglurVSBuAtOWqVw9HMyhZ8iWcfCAabk130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923097.RAddfFcpacvImHglurVSBuAtOWqVw9HMyhZ8iWcfCAabk130_provenance.
• NP655291.RAYhlU0FEbG-XQURjMdeDXA0exgQEw9LJ9oePhBUPbXUw130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655291.RAYhlU0FEbG-XQURjMdeDXA0exgQEw9LJ9oePhBUPbXUw130_provenance.
• assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP946708.RAel2hKxyJXFlhcJ3lb8ZDM11EmvtcQjOsXBCKGMNymQo130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946708.RAel2hKxyJXFlhcJ3lb8ZDM11EmvtcQjOsXBCKGMNymQo130_provenance.
• NP946717.RARnCooPq836kGCbvcRm9QE7DcJ2o5-hK-QASMTxcd2U8130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946717.RARnCooPq836kGCbvcRm9QE7DcJ2o5-hK-QASMTxcd2U8130_provenance.
• NP655335.RAuTJtqbcaLjdh16tByrc5N5f8xekLgAfxl4fIEH4gtog130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655335.RAuTJtqbcaLjdh16tByrc5N5f8xekLgAfxl4fIEH4gtog130_provenance.
• NP888279.RAsAyCpxS2AKuLngSwwWtSRMdMVlHnu5weliqIiSpZ3iY130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888279.RAsAyCpxS2AKuLngSwwWtSRMdMVlHnu5weliqIiSpZ3iY130_provenance.
• NP946707.RAm1tq89nqdmyQX1tWMJs0NIDAPPJkieJODBhyGLZT6qs130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946707.RAm1tq89nqdmyQX1tWMJs0NIDAPPJkieJODBhyGLZT6qs130_provenance.
• NP946718.RAsXGzIDiH-hb0ReMvo_nv4BFCaNoqBr3O7jB2gWkI764130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946718.RAsXGzIDiH-hb0ReMvo_nv4BFCaNoqBr3O7jB2gWkI764130_provenance.
• NP655299.RAP-8psOytjUPtWvvCUVX0ct2EBgy2kubpkhxzf-zlWKw130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655299.RAP-8psOytjUPtWvvCUVX0ct2EBgy2kubpkhxzf-zlWKw130_provenance.
• NP888564.RA6aTaqfOkVHzlrsAOqu1TUeQdtuby70j-KsRbUDRespI130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888564.RA6aTaqfOkVHzlrsAOqu1TUeQdtuby70j-KsRbUDRespI130_provenance.
• NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_provenance.
• NP946709.RA72isZ_n6EUJwEKP4a3sG61osyJ9IzltcQJCdJj2OyPM130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946709.RA72isZ_n6EUJwEKP4a3sG61osyJ9IzltcQJCdJj2OyPM130_provenance.
• NP946710.RA5Swna3q7OCTh17Qkx5mN49r8IluvhLMS6om3B5z91v4130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946710.RA5Swna3q7OCTh17Qkx5mN49r8IluvhLMS6om3B5z91v4130_provenance.